FourThought Financial’s Ascendis Pharma A/S ASND Stock Holding History

FourThought Financial’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$51K	Hold	491	–	–	0.01%	603
2022 Q2	$46K	Buy	491 +41	+9%	+$3.86K	0.01%	632
2022 Q1	$53K	Buy	450 +65	+17%	+$7.53K	0.01%	644
2021 Q4	$52K	Hold	385	–	–	0.01%	647
2021 Q3	$61K	Buy	385 +12	+3%	+$1.64K	0.01%	630
2021 Q2	$49K	Sell	373 -19	-5%	-$2.53K	0.01%	706
2021 Q1	$50K	Sell	392 -26	-6%	-$3.95K	0.01%	687
2020 Q4	$69K	Buy	+418	New	+$69.1K	0.01%	578

Other funds holding ASND

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FourThought Financial's ASND Position: Q3 2022 in Review

FourThought Financial held its Ascendis Pharma A/S (ASND) position steady in Q3 2022 at 491 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #603.

FourThought Financial first reported a position in ASND in Q4 2020 and has held it in 8 quarters since. The position peaked at $69K in Q4 2020. 183 funds tracked by Wall St. Rank hold ASND as of Q3 2022.

FourThought Financial held 491 shares of Ascendis Pharma A/S worth $51K as of Q3 2022.
FourThought Financial left its Ascendis Pharma A/S share count unchanged in Q3 2022.
Ascendis Pharma A/S made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #603 holding.
FourThought Financial first reported a position in Ascendis Pharma A/S in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Ascendis Pharma A/S position peaked at $69K in Q4 2020.
183 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.